Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ).
Global Bio-chem Technology Group Co. Ltd. has announced a Suppliers Debt Restructuring Arrangement involving the re-acquisition of equity interest in Century Dacheng. This arrangement includes a debt-to-equity conversion and an equity-swap, resulting in Century Dacheng becoming an indirect wholly-owned subsidiary of the company again. The restructuring will be settled through the issuance of Consideration Shares, which will significantly affect the company’s share capital. The completion of this arrangement is subject to approval at an Extraordinary General Meeting (EGM), where shareholders will vote on the re-acquisition and the issuance of the Consideration Shares.
More about Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Co. Ltd. operates in the biotechnology industry, focusing on the development and production of bio-chemical products. The company is known for its involvement in the production of corn-based biochemical products and has a significant market presence in the biotechnology sector.
Average Trading Volume: 4,151,537
Technical Sentiment Signal: Buy
Current Market Cap: HK$783.9M
For a thorough assessment of 0809 stock, go to TipRanks’ Stock Analysis page.